CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Shenzhen Neptunus Intrlng Bi tchnq CoLtd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Shenzhen Neptunus Intrlng Bi tchnq CoLtd
1F, Block 1, Research Building
Neptunus Technical Center
Phone: +86 75526411869p:+86 75526411869 SHENZHEN, GNG  518000  China Ticker: 83298329
Business Summary
Shenzhen Neptunus Interlong Bio-Technique Company Limited is a Hong Kong-based company principally engaged in the development, production and sales of medicines. The Company operates through three segments. Medicines segment is engaged in the manufacture and sales of medicines. Medicines and Healthcare Products segment is engaged in the sales and distribution of medicines and healthcare products. Research and Development Services of Modern Biological Technology segment is engaged in the provision of research and development services of modern biological technologies, such as in vitro diagnostics reagents businesses. The products of the Company include herbal medicines, generic drugs, transfusion and anti-tumor drugs, among others. The Company mainly operates businesses in China.
(Source: F-4)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/202312/31/2023Yes----

Industries
SIC Code Description
2834 Pharmaceutical preparations
2833 Medicinal chemicals and botanical products
8731 Commercial physical and biological research
5122 Drugs, drug proprietaries, and druggists' sundries
5912 Drug stores and proprietary stores

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Executive Chairman of the Board, Compliance Officer FengZhang 51 6/25/2011 6/25/2011
Vice General Manager, Joint Company Secretary, Executive Director Jian BoHuang 45 3/22/2022 12/1/2008
Executive Director Xiao GuangZhang 57 6/25/2023 6/25/2023
9 additional Officers and Directors records available in full report.

Business Names
Business Name
8329
BEIJING ZHONGXIN PHARMACEUTICAL CO
Shenzhen Neptunus Interlong Bio-Tech Co.

General Information
Number of Employees: 1,444 (As of 12/31/2023)
Outstanding Shares: 1,678,000,000 (As of 12/31/2023)
Stock Exchange: HKG
Fax Number: +86 75586391610


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Saturday, April 27, 2024